Atea Pharmaceuticals (AVIR) Change in Acquisitions & Divestments (2022 - 2026)

Atea Pharmaceuticals' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $104.3 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 49.92% year-over-year to $104.3 million; the TTM figure through Mar 2026 stood at $366.8 million (down 26.87% YoY), while the FY2025 annual figure was $470.7 million, down 9.0% from the prior year.
• Change in Acquisitions & Divestments was $104.3 million for Q1 2026 at Atea Pharmaceuticals, up from $90.4 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $224.0 million in Q1 2024 to a low of $55.1 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $127.6 million across 5 years, with a median of $111.1 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments soared 64.02% in 2025, then plunged 49.92% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $91.9 million in 2022, then decreased by 18.38% to $75.0 million in 2023, then fell by 26.53% to $55.1 million in 2024, then jumped by 64.02% to $90.4 million in 2025, then grew by 15.38% to $104.3 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $104.3 million (Q1 2026), $90.4 million (Q4 2025), and $56.1 million (Q3 2025), per Business Quant data.